Phase I Trial of Maintenance Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome Post Allogeneic Bone Marrow Transplantation.
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 08 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 08 Nov 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
- 25 Jan 2016 Planned primary completion date changed from 1 Oct 2014 to 1 Oct 2016, as reported by ClinicalTrials.gov.